nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.12.2012 | Letter to the Editor

Will the new advantages provided by PET in myocardial perfusion imaging help nuclear cardiology survive the test of time against conventional radiological techniques?

verfasst von: Federico Caobelli, Davide Farina, Claudio Pizzocaro, Ugo Paolo Guerra

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 12/2012

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sir, …

Flotats A, Bravo PE, Fukushima K, Chaudhry MA, Merrill J, Bengel FM. (82)Rb PET myocardial perfusion imaging is superior to (99m)Tc-labelled agent SPECT in patients with known or suspected coronary artery disease. Eur J Nucl Med Mol Imaging. 2012;39:1233–9.PubMedCrossRef

Berman DS, Hachamovitch R, Shaw LJ, Friedman JD, Hayes SW, Thomson LE, et al. Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: assessment of patients with suspected coronary artery disease. J Nucl Med. 2006;47:74–82.PubMed

Garcia EV, Faber T, Esteves FP. Cardiac dedicated ultrafast SPECT cameras: new designs and clinical implications. J Nucl Med. 2011;52:210–7.PubMedCrossRef

Di Carli MF, Hachamovitch R. Should PET replace SPECT for evaluating CAD? The end of the beginning. J Nucl Cardiol. 2006;13:2–7.PubMedCrossRef

Jerosch-Herold M, Muehling O. Stress perfusion magnetic resonance imaging of the heart. Top Magn Reson Imaging. 2008;19:33–42.PubMedCrossRef

Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet. 2012;379:453–60.PubMedCrossRef

de Jong MC, Genders TS, van Geuns RJ, Moelker A, Hunink MG. Diagnostic performance of stress myocardial perfusion imaging for coronary artery disease: a systematic review and meta-analysis. Eur Radiol. 2012;22:1181–95.

Jaarsma C, Leiner T, Bekkers SC, Crijns HJ, Wildberger JE, Nagel E, et al. Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis. J Am Coll Cardiol. 2012;59:1719–28.PubMedCrossRef

Nabi F, Malaty A, Shah DJ. Stress cardiac magnetic resonance. Curr Opin Cardiol. 2011;26:385–91.PubMedCrossRef

10.

Flotats A, Knuuti J, Gutberlet M, Marcassa C, Bengel FM, Kaufmann PA, et al. Hybrid cardiac imaging: SPECT/CT and PET/CT. A joint position statement by the European Association of Nuclear Medicine (EANM), the European Society of Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC). Eur J Nucl Med Mol Imaging. 2011;38:201–12.PubMedCrossRef

Titel: Will the new advantages provided by PET in myocardial perfusion imaging help nuclear cardiology survive the test of time against conventional radiological techniques?
verfasst von: Federico Caobelli
Davide Farina
Claudio Pizzocaro
Ugo Paolo Guerra
Publikationsdatum: 01.12.2012
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 12/2012
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-012-2214-9

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2012

Biokinetics and dosimetry of 111In-DOTA-NOC-ATE compared with 111In-DTPA-octreotide

Reproducibility of functional volume and activity concentration in 18F-FDG PET/CT of liver metastases in colorectal cancer

Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer’s disease

Prediction models for risk classification in cardiovascular disease

E. Edmund Kim, Doung-Soo Lee, Richard Baum and Ukihide Tateishi (eds): Handbook of Nuclear Medicine and Molecular Imaging: Principle and Clinical Applications

Pretreatment PET in breast cancer: is there a role?